Stay updated on CY, Pembrolizumab, GVAX & SBRT in Locally Adv Pancreatic Ca Clinical Trial
Sign up to get notified when there's something new on the CY, Pembrolizumab, GVAX & SBRT in Locally Adv Pancreatic Ca Clinical Trial page.

Latest updates to the CY, Pembrolizumab, GVAX & SBRT in Locally Adv Pancreatic Ca Clinical Trial page
- Check13 days agoChange DetectedNo significant additions or deletions detected for this page.SummaryDifference0.5%

- Check20 days agoNo Change Detected
- Check42 days agoChange DetectedUpdated operating status notice and version to v3.2.0, replacing v3.1.0.SummaryDifference4%

- Check49 days agoChange DetectedUpgrade version from v3.0.2 to v3.1.0; no other content changes are specified.SummaryDifference0.1%

- Check63 days agoChange DetectedUpdated page revision from v3.0.1 to v3.0.2; removed the Back to Top link.SummaryDifference0.3%

- Check71 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.3%

- Check78 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as new medical and therapeutic terms related to cancer treatment, such as 'pembrolizumab' and various procedures. Notably, previous references to specific locations and certain medical resources have been removed.SummaryDifference5%

Stay in the know with updates to CY, Pembrolizumab, GVAX & SBRT in Locally Adv Pancreatic Ca Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CY, Pembrolizumab, GVAX & SBRT in Locally Adv Pancreatic Ca Clinical Trial page.